<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">Antiviral treatments have been shown by clinical observation and research to have certain effects in COVID-19 therapy. According to Chinaâ€™s New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 8), drugs with potential antiviral effects should be used early in the course of the disease, and it is recommended to focus on patients with high risk factors for severe illness patients. Lopinavir/ritonavir and ribavirin alone are not recommended for COVID-19 patients.</p>
